New York, Sept. 27, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Market.us, the Global Implantable Cardioverter Defibrillator Market size is expected to be worth around USD 7.7 Billion ...

Targeted ICD selection based on predicted therapy benefit enhances patient outcomes while cutting hospital costs by 16.7%.

New research from the University of Minnesota Medical School demonstrates that using cardiovascular magnetic resonance imaging—known as CMR phenotyping—can help identify patients with suspected ...

Cite this: Recurrence of Atrial Tachyarrhythmias in Implantable Cardioverter-Defibrillator Recipients - Medscape - Oct 01, 2005. Abstract and Introduction Methods ...

Implantable cardioverter defibrillator (ICD) Doctors mainly use ICDs to treat ventricular tachycardia and ventricular fibrillation, two life-threatening heart rhythms.

Surge in contributing factors such as obesity and sedentary lifestyle is a key factor driving revenue growth of the global implantable cardioverter defibrillator market to a significant ...